Showing 35,658 results

Transmission & prevention

PrEP could prevent up to three million HIV infections in ten years in Africa

News
25 September 2007
How HIV works

HIV replication can continue in the intestines even with successful antiretroviral therapy

News
25 September 2007
Side effects

Urinary stones a rare side-effect of atazanavir

News
24 September 2007
Hepatitis & HIV

Sexual transmission of hepatitis C in HIV-positive gay men reported in Australia

News
24 September 2007
The search for an HIV prevention vaccine

Merck HIV vaccine fails, trials halted

News
22 September 2007

ICAAC: Serious but non-AIDS-defining illnesses more frequent at lower CD4 counts and higher viral loads

News
21 September 2007
New & experimental HIV treatments

ICAAC: No drug interactions found between TMC125 and ritonavir-boosted elvitegravir

News
21 September 2007
Side effects

ICAAC: Gains in limb fat and CD4 counts continue three years after switching from d4T to tenofovir

News
21 September 2007
Transmission & prevention

Return of nelfinavir's European license recommended

News
21 September 2007
Resistance

ICAAC: Cross-resistance to 3TC and FTC develops slowly with entecavir monotherapy

News
21 September 2007
New & experimental HIV treatments

ICAAC: Phase 1 study provides `proof of concept` for PRO 140, a monoclonal CCR5 antibody

News
21 September 2007
People with limited treatment options

ICAAC: 48-week results show maraviroc still potent in highly treatment-experienced

News
20 September 2007
Epidemiology

ICAAC: Sharp decline in HIV prevalence reported in pregnant women in rural northern Zimbabwe

News
20 September 2007
New & experimental HIV treatments

ICAAC: Maraviroc failures associated with shifts from R5-tropic to mixed or X4-tropic HIV

News
20 September 2007
New & experimental HIV treatments

ICAAC: Dapivirine safe and tolerable as potential vaginal microbicide; displays potential in combination with other agents

News
20 September 2007
Cancer

ICAAC: Incidence of non-AIDS-defining cancers remains higher for HIV-positive individuals despite HAART

News
20 September 2007
Sexually transmitted infections prevention

ICAAC: Gardasil provides some protection against wide spectrum of cancer-causing HPV

News
19 September 2007
How HIV works

ICAAC: Dual/mixed tropic virus speeds disease progression as much as tenfold increase in viral load

News
19 September 2007
Treatment interruptions

ICAAC: In NNRTI-based regimens, stepwise discontinuation minimises risk of antiretroviral resistance

News
19 September 2007
People with limited treatment options

ICAAC: Raltegravir shows sustained effect in highly treatment-experienced patients

News
19 September 2007
Starting treatment

ICAAC: Boosted darunavir non-inferior to boosted lopinavir after 48 weeks in treatment-naïve

News
19 September 2007
People with limited treatment options

ICAAC: Best response to elvitegravir seen when used with T-20 and other active agents

News
19 September 2007
People with limited treatment options

ICAAC: Vicriviroc safe, effective after 2 years, phase III studies start soon

News
19 September 2007

HIV Weekly - September 19th 2007

September 2007